RIO DE JANEIRO, June 11, 2024 (GLOBE NEWSWIRE) - FII Institute is honoured to announce that Brazil's President Luiz Inácio Lula da Silva will speak at the inaugural Latin America FII PRIORITY Summit in Rio de Janeiro on 12 June, marking a significant milestone for the summit.
President Lula, who will be joined by several high-ranking Brazilian and Latin American government officials, underscores the importance of FII PRIORITY Rio in addressing key global priorities and promoting investment opportunities. His attendance is a testament to Brazil's integral role in shaping the future of global investment and sustainability.
“We are deeply honoured by President Lula's decision to join us," said Richard Attias, CEO of FII Institute. "As a global leader, his leadership and vision will greatly enrich our discussions and initiatives. The theme of our summit, ‘Invest in Dignity,' was inspired by President Lula's vision.”
The FII PRIORITY Rio de Janeiro Summit will take place at the Copacabana Palace from 11 to 13 June 2024, featuring a rich and diverse programme with world-renowned leaders and critical discussions on global issues.
For more information, please visit: https://fii-institute.org/Program-Rio. For media enquiries, please email: media@fii-institute.org and fii-institute@fsb.com.br.
About FII Institute
The Future Investment Initiative (FII) Institute is a global non-profit foundation driven by data with an investment arm focused on impactful initiatives for humanity. Through its PRIORITY Summits, the institute brings together leading minds to foster innovation and sustainable solutions across the globe.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b35d9202-dd4a-42c5-8e66-d4bd1dcf5749
-
2024 芳华绝代的姐姐·第二季首赛在成都启幕2024 年 6 月 9 日,备受瞩目的《2024 芳华绝代的姐姐·第二季》首战在成都金牛万达广场拉开序幕,近300 位参赛选手参与了此次成都赛区初赛,报名采用线上线下同步进行2024-06-17
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17